We investigated hematopoietic growth factor (HGF) and cytokine gene expression in the bone marrow (BM) and peripheral blood (PB) of healthy individuals as a starting point for delineating the physiologic role of cytokines in steady state hematopoiesis. BM biopsy specimens and PB samples from 7 healthy individuals were analyzed by polymerase chain reaction amplification of reverse-transcribed RNA using gene-specific primer sets. Consistent gene expression in the BM of all 7 individuals was detected for macrophage colonystimulating factor ICSF), stem cell factor, interleukin-6 [IL-6), IL-7, erythroid-potentiating factor, erythroid-differentiating factor, and insulinlike growth factor 1, all cytokines with reported direct stimulatory effects on in vitro hematopoiesis. Of these, erythroid-potentiating factor and erythroid-diiferentiating factor appeared to be the only stimulating factors that were also expressed in the PB. Among the cytokines with inhibitory effects on in vitro hematopoiesis IL-4, tumor necrosis factor-a (TNF-a), TNF-p, transforming growth factor-p, and macrophage inflammatory protein-la were expressed in the BM of the 7 individuals. Except for HE DEVELOPMENT OF hematopoiesis from hematopoietic progenitor cells (HPCs) to mature blood cells has been studied extensively in vitro. It has been shown that the in vitro proliferation and differentiation of HPCs is dependent on the presence of specific hematopoietic growth factors (HGFs). Apart from the specific HGFs, many other cytokines have been found to affect in vitro hematopoiesis.' However, the relevance of these in vitro data for in vivo hematopoiesis is not clear. It has been hypothesized that in vivo hematopoiesis can be distinguished in a constitutive and an inducible part and that it is regulated at two levels, in the bone marrow (BM) microenvironment, in an autocrine or paracrine fashion, and at extramedullary sites in an endocrine fashion.'.* In this concept, constitutive or steady state hematopoiesis is autonomously regulated in the BM microenvironment by direct cell to cell contact between HPCs and BM stroma cells, by proteins that constitute the extracellular matrix, and by locally produced cytokines. Inducible hematopoiesis occurs whenever there is an increased need for mature blood cells, eg, in the case of infection and inflammation, after loss or increased destruction of mature blood TNF-a, the latter cytokines were also expressed in the PB. Consistent expression in the BM and P6 of all tested individuals was also observed for IL-lB, IL-l receptor antagonist, and IL-1p converting enzyme, which are all members of the IL-l family with a possible indirect effect on hematopoiesis.
HE DEVELOPMENT OF hematopoiesis from hematopoietic progenitor cells (HPCs) to mature blood cells has been studied extensively in vitro. It has been shown that the in vitro proliferation and differentiation of HPCs is dependent on the presence of specific hematopoietic growth factors (HGFs). Apart from the specific HGFs, many other cytokines have been found to affect in vitro hematopoiesis.' However, the relevance of these in vitro data for in vivo hematopoiesis is not clear. It has been hypothesized that in vivo hematopoiesis can be distinguished in a constitutive and an inducible part and that it is regulated at two levels, in the bone marrow (BM) microenvironment, in an autocrine or paracrine fashion, and at extramedullary sites in an endocrine fashion.'.* In this concept, constitutive or steady state hematopoiesis is autonomously regulated in the BM microenvironment by direct cell to cell contact between HPCs and BM stroma cells, by proteins that constitute the extracellular matrix, and by locally produced cytokines. Inducible hematopoiesis occurs whenever there is an increased need for mature blood cells, eg, in the case of infection and inflammation, after loss or increased destruction of mature blood
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2038 TNF-a, the latter cytokines were also expressed in the PB. Consistent expression in the BM and P6 of all tested individuals was also observed for IL-lB, IL-l receptor antagonist, and IL-1p converting enzyme, which are all members of the IL-l family with a possible indirect effect on hematopoiesis.
Remarkably, no expression of granulocyte CSF. granulocytemacrophage CSF, and IL-3 was found in the BM or PB of all investigated individuals (n = 15). This was also the case for IL-la, IL-2, IL-5, IL-9, IL-12, IL-13, leukemia-inhibiting factor, interferon-y, and inhibin. Weak IL-8 and IL-l0 expression was found in the BM and/or PB of a minority of investigated individuals. These findings provide insight into which cytokines or HGFs potentially are involved in the autocrine or paracrine regulation of in vivo steady state hematopoiesis. The absence of expression of granulocyte CSF, granulocytemacrophage CSF, and IL-3 in the BM of healthy individuals implicates that it is highly unlikely that these HGFs are involved in the autocrine or paracrine regulation of constitutive hematopoiesis. 0 1995 by The American Society of Hematology.
cells, or after myelosuppressive or myeloablative events. It is conceivable that inducible hematopoiesis is regulated both in an autocrine/paracrine fashion and by endocrine routes. As a starting point for delineating the physiologic role of cytokines and HGFs in the paracnne/autocrine regulation of hematopoiesis in vivo, gene expression of a large number of cytokines was analyzed in BM biopsy specimens, BM aspirates, and the peripheral blood (PB) of healthy individuals. The cytokines and HGFs investigated were chosen because of there known direct stimulatory or inhibitory effects on in vitro hematopoiesis or because of their potential or observed indirect modulating effect on in vitro hematopoiesis. In vivo cytokine and HGF gene expression was assessed using the reverse polymerase chain reaction (PCR) method. This approach facilitates the analysis of a great number of genes in small samples of BM and PB and is sensitive enough to detect low, but probably relevant, levels of mRNA expression.
MATERIALS AND METHODS
BM and PB samples. After obtaining informed consent, BM (1 to 2 mL) was aspirated, and a biopsy specimen (at least 2 cm in length) was taken from the iliac crest of normal healthy individuals and, within 1 minute, was fragmented and homogenized in guanidium thiocyanate extraction solution to exclude in vitro cytokine and HGF gene induction and to prevent loss of mRNA by degradation. Buffy coats of heparinized PB were washed once in phosphatebuffered saline and homogenized in guanidium thiocyanate extraction solution.
RNA exrraction, cDNA synthesis, and PCR ampljfication. Total cellular RNA was isolated by the guanidium-thiocyanate-phenolchloroform extraction procedure with minor modifications as described previo~sly.~ From 2 pg of the RNA samples, the mRNA fraction was reverse-transcribed into cDNA using 400 U reverse mmol/L MgC12, 0.5 mmoVL of each dNTP (Pharmacia, Uppsala, Sweden), and 5 pg acetylated bovine serum albumin (Promega). The criteria for selection of oligonucleotide primers, primer sequences for some cytokines, and the method of synthesis have been described before? Primer sequences that we have not published before are listed in Table 1 . With the exception of interleukin-l2 (IL-12), transforming growth factor-@l (TGF-@l), and erythroid-differentiating factor (EDF), primer sequences were complementary to different exons of the genes facilitating the distinction between cDNA amplification products and contaminating genomic DNA products. For IL-12, TGF-@l and EDF, PCR was repeated on cDNA that was synthesized from RNA samples that were pretreated with DNAse (Boehringer Mannheim GmbH, Mannheim, Germany), in case significant amounts of PCR products were observed. No EPA, ICE, IL-IRA, and M P -l a expression was found in human genomic DNA samples and Balb-c mice BM cDNA. TGF-p and EDF were not expressed in cDNA from 3T3, a murine fibroblast cell line. To control for cDNA loss, B-actin expression was repeatedly tested after a series of PCR experiments.
RESULTS
From preliminary experiments a semiquantitative distinction of cytokine and HGF mRNA expression was derived based on the presence and intensity of bands on agarose gels obtained after 32, 40, or 60 PCR cycles. The amount of cDNA from each sample was corrected according to @-actin expression after 22 cycles of amplification.
First, the expression patterns of BM aspirates and BM biopsy specimens were compared. Except for the macrophage CSF (M-CSF) gene, no obvious differences were found in 5 healthy donors. M-CSF appeared to be consistently higher expressed in BM biopsy specimens compared with aspirates (data not shown). Because BM biopsy specimens provide an integral sample of BM stroma and HPCs, we preferred to use BM biopsy specimens in this study for further analysis.
Among the cytokines with a demonstrated in vitro direct stimulatory effect on hematopoiesis, consistent constitutive gene expression was found in BM biopsy specimens for IL-6, E-7, SCF, M-CSF, EPA, EDF, and IGF-l in all 7 investigated individuals (Fig 1) . M-CSF, IL-7, EPA, EDF, and IGF-1 were readily detectable after 32 PCR cycles (Table 2). EDF and EPA gene expression was uniformally observed in the PB samples, in contrast to the IL-6, IL-7, M-CSF, SCF, and IGF-1 gene that did not show expression in the PB of the 7 individuals. No expression, with clear positive controls, was found in BM biopsy specimens or in the PB of G-CSF, GM-CSF, IL-3, E -5 , IL-9, and LW gene, all of which are cytokines that have been associated with in vitro stimulation of hematopoiesis (Table 2) . In Fig 2, it is shown that the G-CSF, GM-CSF, and IL-3 gene are not expressed in the BM after 40 and 60 PCR cycles, whereas the positive control samples show an increased intensity of the bands after increasing the amplification from 40 to 60 cycles. The sensitivity of the applied PCR assay was investigated using series of IO-fold dilutions of the positive control samples. It appeared that G-CSF, GM-CSF, and IL-3 could be detected in IO-' to dilutions of the control sample (Fig 3) . For comparison, in Fig 2 is also shown the expression of G-CSF, GM-CSF, and IL-3 in a cDNA sample obtained from an inflamed appendix. To extend the surprising negative results regarding G-CSF, GM-CSF, and IL-3 expression in the BM of the 7 individuals tested, BM biopsy specimens of 8 additional healthy individuals were investigated. Again, no G-CSF, GM-CSF, or IL-3 expression could be observed ( Table 2 ). The data in Fig 2 are representative for the other cytokines investigated that did not show expression in BM and/or PB samples.
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Among the cytokines with a demonstrated inhibitory effect on in vitro hematopoiesis, significant gene expression was found both in the BM and the PB of all 7 individuals for IL-4, TNF-p, TGF-p, and MIP-la, albeit with varying intensity ( Table 3) . The TNF-a gene was clearly expressed in 3 of the 7 individuals and only weakly expressed in the remaining 4, whereas no TNF-a gene expression was detectable in the PB of all 7 persons. No IFN-y and inhibin expression was observed in the BM or PB of the 7 individuals tested.
The remaining cytokines investigated have in common the capacity to regulate the immune and/or the inflammatory response and, indirectly, can influence hematopoiesis by the induction of cytokines with a direct effect on hematopoiesis or by attracting cells with the potential to produce the latter cytokines. Clear expression of the IL-lp, IL-I RA, and ICE gene was found in the BM and PB of all individuals ( Table  4) . No gene expression could be observed in the BM and PB for IL-la (n = 15). IL-2, IL-12, and IL-13. After 60 PCR cycles expression of IL-8 and IL-IO gene was detected in the BM of 1 and 3 individuals, respectively; whereas, in the PB of 2 individuals, IL-8 expression was found, but IL-IO was not detectable in any of the individuals.
DISCUSSION
To study which HGFs and other cytokines are potentially involved in the autocrine/paracrine regulation of normal steady state hematopoiesis in vivo, we have searched for cytokine gene expression in BM biopsy specimens and aspirates and in the PB of healthy individuals.
No G-CSF, GM-CSF, IL-3, IL-5, IL-9, and LIF gene expression could be detected in the 2 types of BM samples of all individuals tested. This observation could indicate that these cytokines do not play a significant role in the paracrine or autocrine regulation of steady state hematopoiesis in the BM microenvironment. Especially for G-CSF, GM-CSF, and IL-3, this is an unexpected finding considering the role that these cytokines play in hematopoietic growth and differentiation in Low levels of G-CSF and GM-CSF have recently been detected in the serum of normal individuals, suggesting that these HGFs may play an endocrine regulatory role in steady state hematop~iesis.'"~~ Although IL-3 could not be detected in the serum of normal individuals, it is still conceivable that it circulates at very low levels and also acts by endocrine routes.25 Moreover, these observations do not exclude the possibility that G-CSF, GM-CSF, and IL-3 take part in the autocrine/paracrine regulation of inducible hematopoiesis.
The consistent expression of the SCF, M-CSF, IL-6, EDF, EPA, and IGF-l gene in the BM is in accordance with in vitro data that these cytokines are regulators of the proliferation and differentiation of early HPCs (SCF, IL-6, and EDF) andor committed HPCs (IL-6, M-CSF, EDF, EPA, and IGFbe of importance for the homing, survival, and function of macrophages in the BM.3' In view of the published data, it may be that the expression of M-CSF and IL-6 in BM biopsy specimens reflects their regulatory role in bone metaboline with the observation that IL-7 stimulates the in vitro The consistent expression of IL-4, TNF-a. TNF-P, TGF-0, and MIP-la, all cytokines that have been shown to be able to inhibit in vitro hematopoiesis, suggests that, also in the BM microenvironment, hematopoiesis is subject to suppressive factors.394h A third group of cytokines has been studied for their expression in BM because they potentially can influence hematopoiesis indirectly by inducing or suppressing HGFs and cytokines with a direct effect on hematopoiesis, by modulating cytokine receptor expression on HPCs, or by attracting not shown differential expression, except for quantitative differences, of these genes.'" The expression of the ICE gene indicates not only that the generation of the precursor form of IL-lP is possible in the BM but also that processing to its active moiety can be expected. 48 The consistent expression of IL-1RA is in line with the observation that all members of the IL-1 family can be expressed by the same kind of cells:' Although the analysis of BM biopsy specimens does not give information about the cellular sources of the cytokines expressed, the cytokine expression profile in BM and PB samples, together with the available data from the literature, may give some clues to which cells constitutively express cytokines. The finding that M-CSF, SCF, IL-6, L-7, IGF-1, and TNF-a are expressed in BM cells and not in PB cells suggests that they are expressed in BM stroma cells or in nonstromal BM accessory cells that do not circulate in the PB. With regard to the cytokines that are expressed both in the BM and PB, monocytes are the likely sources of EDF, EPA, MIP-la, IL-1P, IL1-RA, and TGF-P, although the latter probably is also expressed in the BM by megakaryocytes because platelets have been established as a rich source of this ~ytokine:~,~~-~' Based on in vitro data, the likely source that could account for the expression of the remaining two cytokines, TNF-P and L-4, is activated T lymphocytes. However, in vitro, activated T lymphocytes express a variety of cytokines such as IL-2, IL-3, IL-5, K-6, and y-IFN, none of which were shown to be expressed both in the BM and PB of the healthy individuals we have studied?2 Thus, it is unlikely that activated T lymphocytes circulating in the PB or residing in the BM are the source of constitutively expressed TNF-0 and IL-4. According to in vitro data, IL-4 is possibly expressed by cells belonging to the mast cell and/ or basophil lineage.53 Beause the observed lymphokine expression profile in the BM and PB suggests the absence of activated T cells, it is highly unlikely that there exists an autologous proliferative T-cell response that regulates in vivo steady state hematopoiesis, as has been inferred from in vitro observation^.^^
In conclusion, no G-CSF, GM-CSF, and IL-3 gene expression was found in the BM and PB of healthy individuals. Therefore, it is unlikely that G-CSF, GM-CSF, and IL-3 take part in the autocrindparacrine regulation of steady state hematopoiesis. It remains to be determined whether these HGFs are of relevance for the autocrindparacrine regulation of inducible hematopoiesis. Other cytokines, specifically M-CSF, SCF, LL-lP, IL-6, IL-7, EPA, EDF, and IGF-I, with observed direct or indirect stimulatory effects on in vitro hematopoiesis, were strongly detectable in the BM, whereas cytokines with inhibitory effects on in vitro hematopoiesis, such as L-4, TNF-P, TGF-P, and MIP-la, appeared to be expressed both in the BM and PB of all healthy individuals tested.
